News Alert: autoimmunity diagnostics market to Cross $8.98B by 2031
The report "Autoimmunity Diagnostics Market by Product (Consumables, Instruments), Test Type (Routine, Autoantibody, Inflammatory, Urinalysis Tests), Disease (RA, SLE, MS, IBD), End User (Clinical Laboratories, Hospitals & Clinics) - Global Forecast to 2031" is projected to reach USD 8.98 billion by 2031 from USD 5.57 billion in 2025, at a CAGR of 8.3% during the forecast period.
Browse 312 market data Tables and 57 Figures spread through 296 Pages and in-depth TOC on "Autoimmunity Diagnostics Market - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/autoimmune-disease-diagnosis-market-174826519.html
The autoimmunity diagnostics market is witnessing robust growth, driven by several key factors. A primary driver is the rising global prevalence of autoimmune disorders, including both systemic autoimmune diseases and organ-specific autoimmune diseases, which is significantly increasing the demand for reliable and timely diagnostic solutions. Additionally, there is a notable rise in research activities focused on autoimmune diseases, contributing to the development of advanced testing methods. Technological advancements are also crucial; innovative diagnostic tools enable faster, more accurate, and earlier detection of these conditions. Furthermore, expanding healthcare infrastructure, particularly in emerging markets, improves access to diagnostic services, fueling overall market growth.
The consumables segment is expected to register the highest CAGR during the forecast period.
Based on product, the autoimmunity diagnostics market is divided into two segments: consumables and instruments. The consumables segment accounted for the highest CAGR over the forecast period, which was led by the continuous need for consumables for various diagnostic tests. This growth is driven by the increasing frequency of autoimmune disease testing, the rising adoption of advanced immunoassay kits, and the preference for single-use consumables that ensure accuracy and reduce contamination risks. Additionally, ongoing innovations in reagent formulations and the expanding availability of specialized consumables for different autoimmune conditions further contribute to the robust growth of this segment.
The organ-specific autoimmune diseases segment is expected to register the highest CAGR during the forecast period.
Based on disease type, the global autoimmunity diagnostics market is divided into systemic autoimmune disease and organ-specific autoimmune disease. The organ-specific autoimmune diseases segment accounted for the highest CAGR during the forecast period due to the rising prevalence of organ-specific conditions like type 1 diabetes, celiac disease, and inflammatory bowel disease, and other. Additionally, increasing adoption of targeted diagnostic tests, growing awareness about early and accurate diagnosis, and advancements in technologies enabling quicker, more precise detection of organ-specific autoantibodies are driving rapid market growth in this segment.
North America accounted for the largest share of the autoimmunity diagnostics market in 2024.
The market for autoimmunity diagnostics is segmented into five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the market in 2024. The large share of this region is primarily attributed to the high growth presence of countries such as the US and Canada. These countries have established healthcare infrastructure and high healthcare spending, thus supporting the adoption of advanced autoimmunity diagnostics products. The region also experiences a high incidence of autoimmune diseases. The availability of key players and R&D investments are also expected to sustain market growth.
The leading players operating in this market are F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Revvity, Inc. (US), Thermo Fisher Scientific Inc. (US), Siemens Healthineers AG (Germany), Bio-Rad Laboratories, Inc. (US), Danaher Corporation (US), Werfen S.A. (Spain), Grifols S.A. (Spain), and QuidelOrtho Corporation (US).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook.
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Autoimmunity Diagnostics Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
